Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05912608 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Optimal Strategy for Repair of Type A Acute Aortic Dissection

Study acronym: TARAD
StatusEnrolling by Invitation
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study completion date: Dec 31, 2025 to Dec 31, 2026v10
  2. Enrollment target: 600 to 900
    • Start date: Oct 30, 2023 to Jan 1, 2024
    • Site details revised
    • Publications: details revised at 6 of 6 entries
    v9
  3. Primary completion date: Dec 30, 2024 to Jun 30, 2025
    • Enrollment target: 800 to 600
    • Study completion date: Dec 31, 2024 to Dec 31, 2025
    • Collaborators: 3 to 4
    v8
  4. Phase: Not specified to Not applicable
    • Site details revised
    • Publications: details revised at 6 of 6 entries
    v7
  5. Collaborators: 5 to 3v6
Show 4 earlier versionsHide 4 earlier versions
  1. Primary completion date: Mar 30, 2024 to Dec 30, 2024v5
  2. Primary completion date: Dec 30, 2023 to Mar 30, 2024
    • Study completion date: Mar 31, 2024 to Dec 31, 2024
    v4
  3. Collaborators: 4 to 5v3
  4. Trial status: Not Yet Recruiting to Enrolling by Invitation
    • Study sites: 0 to 1
    • Start date changed from estimate of Sep 1, 2023 to Oct 30, 2023
    v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Acute type A aortic dissection (TAAD) persists as a clinicopathologic entity with high lethality in the current era. Several procedures are presently used to repair the TAAAD. The objective of this study is to analyze two groups of individuals using a conservative approach through root-sparing and hemiarch techniques in patients who are hospitalized in higher-risk clinical conditions or more aggressive procedures such as root replacement and total arch replacement in low-risk patients.
Trial Details
NCT Number NCT05912608
Lead Sponsor Centre Cardiologique du Nord
Collaborators: Henri Mondor University Hospital, Universita degli Studi di Genova, Pitié-Salpêtrière Hospital, Ospedale San Camillo, Rome, Italy
Conditions
(from sponsor)		 Aortic Dissection
Related terms Aortic Dissection
Enrollment 900 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov